Kimberly-ClarkKMB
KMB logo
Fair Value
US$117
Share price31 Jul
US$108.667.1% undervalued intrinsic discount
Loading
1Y-20.55%
7D-1.39%

KMB: Future Margin Improvements Will Drive Upside Amid Market Uncertainty

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
06 Aug 24
Updated
31 Jul 26
Views
1.4k
Not Invested

Last Update 31 Jul 26

Fair value Increased 2.03%

KMB: Future Returns Will Depend On Kenvue Integration And High-Margin Powerhouse Potential

Kimberly-Clark's fair value estimate has shifted to $117.00 from $114.67 as analysts factor in higher price targets, currently clustered in the $110 to $121 range, and their view that the Kenvue deal could add meaningful value over time despite integration risks and initially limited contribution to near term forecasts.

Analyst Commentary

Recent commentary around Kimberly-Clark highlights a mix of optimism about the Kenvue transaction and caution around execution risk and timing. Price targets now cluster between $110 and $121, with most analysts keeping neutral or equal weight stances despite these adjustments.

Bullish Takeaways

  • Bullish analysts see room for Kimberly-Clark shares to align with price targets in the low to mid $110s. This informs the updated fair value estimate of $117.00.
  • Some price targets move toward the upper end of the current range at $121. This reflects confidence that the Kenvue deal can add meaningful value over time even if it is not yet modeled in full detail.
  • Supportive commentary points to potential upside from the Kenvue integration beyond current forecasts once the combined business structure and segment splits become clearer.
  • The consistency of higher targets across several firms suggests that the market is starting to factor in the longer term benefits of the transaction, even if analysts retain more balanced ratings today.

Bearish Takeaways

  • Bearish analysts highlight fundamental risk tied to integrating Kenvue, including the need to execute on both legacy Kimberly-Clark operations and the acquired assets at the same time.
  • There is concern that expectations for underlying growth at both Kimberly-Clark and Kenvue, as well as assumed synergies, may be set too high relative to what is currently visible.
  • Some commentary points out that upside from the deal is not expected to meaningfully affect modeled outcomes for several years. This can limit near term valuation support.
  • Neutral and equal weight ratings alongside raised price targets signal that analysts still see a balance between potential long term benefits and integration and execution risks in the medium term.

What’s in the News for Kimberly-Clark

  • Commentator Jim Cramer described Kimberly-Clark’s planned acquisition of Kenvue, Johnson & Johnson’s consumer health business, as creating a high margin defensive powerhouse with exposure to brands such as Tylenol, Neutrogena, Listerine and Band-Aids. Source: recent television commentary summarized in news reports.
  • Cramer’s commentary highlighted expectations that the Kenvue deal could support revenue growth, improve margins and create cost reduction opportunities over time. This reinforced the view that the combined consumer health and tissue portfolio may provide steady cash flow through different economic cycles. Source: same commentary.
  • Kimberly-Clark was dropped from the Russell Top 200 Index and from the Russell Top 200 Value and Growth Benchmarks, and was added to the Russell Midcap Index as well as the Russell Midcap Growth and Midcap Value Benchmarks, reflecting reclassification within the Russell index family rather than a company specific announcement.
  • Pull-Ups, a Kimberly-Clark brand, announced Learning Layer technology for its training pants, which briefly feels wet before drying to help toddlers notice accidents while still aiming to contain mess and protect sensitive skin, with availability at major US retailers including Target, Walmart and Amazon.
  • Kleenex, another Kimberly-Clark brand, launched Kleenex Snap & Go, a durable on the go tissue pack with a secure snap lid and 25 Kleenex Ultra Soft 3 layer tissues per pack, now available online at Amazon, Target and Walmart with broader US retail availability scheduled from May.

Valuation Changes for Kimberly-Clark

  • Fair Value has risen slightly from $114.67 to $117.00, reflecting modest adjustments to the underlying assumptions for Kimberly-Clark.
  • Discount Rate is effectively unchanged at about 7.11%, indicating a consistent risk and return profile used in the valuation work.
  • Revenue Growth assumption has fallen slightly from 3.54% to 3.49%, which points to a marginally more cautious view on future revenue expansion.
  • Net Profit Margin assumption has edged down from 14.82% to 14.81%, suggesting a very small adjustment to expected earnings efficiency over the forecast period.
  • Future P/E multiple has risen slightly from 17.18x to 17.57x, signaling a modestly higher valuation multiple being applied to Kimberly-Clark’s expected earnings.
9 viewsusers have viewed this narrative update

Key Takeaways

  • Prioritizing innovation, brand strength, and premium offerings enables resilience against competition and shifting consumer preferences, supporting long-term growth and margin expansion.
  • Strategic focus on high-growth segments and disciplined cost management is enhancing efficiency, positioning Kimberly-Clark for sustained revenue and operating profit improvement.
  • Heightened competition, weaker global consumer demand, reliance on innovation, portfolio concentration, and cost-cutting measures threaten Kimberly-Clark's pricing power, growth prospects, and long-term competitiveness.

Catalysts

About Kimberly-Clark
    Manufactures and markets personal care products in the United States.
What are the underlying business or industry changes driving this perspective?
  • Robust global and North American consumption trends for essential personal care and hygiene products-bolstered by innovation and brand reinvestment-position Kimberly-Clark to benefit from ongoing population growth and rising health/hygiene consciousness, supporting volume growth and long-term revenue expansion.
  • Continued innovation across premium and mid-tier product lines, combined with effective go-to-market strategies and increased in-house marketing capabilities, allows Kimberly-Clark to capitalize on durable demand for premiumized and differentiated hygiene solutions, supporting structural net margin expansion.
  • Strategic refocus on higher-growth, higher-margin North America and International Personal Care segments (post-Suzano JV) is expected to accelerate revenue and gross margin growth-aligned with long-term demographic shifts such as aging populations requiring more adult care and healthcare-related products.
  • Disciplined cost management (including targeted SG&A savings, productivity initiatives delivering 5%–6% of COGS, and digital/automation investments) is enhancing operating efficiency, providing earnings and margin tailwinds that support attainment of multi-year gross margin and operating profit milestones.
  • Strong brand equity and innovation pipeline position Kimberly-Clark to defend and grow share amid intensifying industry competition and shifting consumer preferences-reinforcing resilience in core categories, supporting pricing power, and driving sustainable EPS growth.
Kimberly-Clark Earnings and Revenue Growth

Kimberly-Clark Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Kimberly-Clark's revenue will grow by 3.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 10.4% today to 14.8% in 3 years time.
  • Analysts expect earnings to reach $2.7 billion (and earnings per share of $6.81) by about July 2029, up from $1.7 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $2.3 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 17.6x on those 2029 earnings, down from 21.3x today. This future PE is lower than the current PE for the US Household Products industry at 21.1x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.11%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Increased competitive intensity from private label and promotional activity in key categories (such as U.S. tissue and diapers) may pressure Kimberly-Clark's pricing power and require higher promotional spend, potentially compressing gross margins and limiting margin expansion.
  • The underlying consumer environment remains challenged by weak purchasing power, especially in lower-income and informal economies, leading to frequency declines and limiting volume growth in certain international markets-potentially slowing overall revenue growth.
  • Heavy dependence on continuous innovation for both premium and mid-tier products means that any slowdown in R&D success or failure to deliver meaningful differentiation could reduce the company's ability to sustain volume/mix-driven revenue and margin growth.
  • The recent divestiture of the International Family Care and Professional business (IFP) through the JV with Suzano further concentrates the company's reliance on North America and Personal Care categories; adverse trends in these segments (e.g., shrinking diaper market due to declining birth rates) could have an outsized impact on future revenue and earnings.
  • Ongoing restructuring, cost-cutting, and focus on in-housing marketing/creative functions, while driving near-term productivity gains, may risk underinvestment in long-term brand equity and innovation, potentially weakening the competitive moat and negatively impacting long-term return on capital and earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $117.0 for Kimberly-Clark based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $162.0, and the most bearish reporting a price target of just $90.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $18.4 billion, earnings will come to $2.7 billion, and it would be trading on a PE ratio of 17.6x, assuming you use a discount rate of 7.1%.
  • Given the current share price of $110.19, the analyst price target of $117.0 is 5.8% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Kimberly-Clark?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$117
vs US$108.667.1% undervalued intrinsic discount
PastFuture020b2015201820212024202620272029Revenue US$18.4bEarnings US$2.7b
3.5%
Revenue growth
14.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Kimberly-Clark

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Good value average dividend payer.

Market capUS$37.4b
PB20.7x
Estimated Growth2.5%
Dividend Yield4.7%
Full analysis

CEO & management

Michael Hsu
CEO
3.2yrs
CEO Tenure

Manufactures and markets personal care products in the United States.